微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | -9.16% | 48.54% | 47.11% | 136/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -17.32% | -26.98% | -59.78% | 148/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -10.84% | -146.36% | 85.43% | 144/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -74.41% | -128.25% | -318.03% | 148/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -17.8% | -138.93% | -30.5% | 143/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -13.64% | -319.69% | -210% | 146/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -4.4% | -1036.17% | 86.5% | 136/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -32.6% | -28.45% | -337.58% | 143/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -7.45% | -152.54% | -129.23% | 127/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -3.25% | -63.32% | -791.49% | 131/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.47% | -72.02% | 101.85% | 107/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -25.38% | -853.12% | -760.34% | 139/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -2.95% | -194.25% | -48.24% | 123/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -1.99% | -176.54% | -218.45% | 123/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.68% | 26.32% | -50.15% | 76/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 3.37% | -55.66% | 7.67% | 97/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 3.13% | -40.15% | 20.38% | 82/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.6% | -43.84% | 95.49% | 79/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 1.33% | -43.88% | -82.5% | 62/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 7.6% | 15.33% | 45.32% | 75/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 5.23% | -1.88% | 12.96% | 65/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.63% | 5.71% | 95.36% | 54/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.37% | -1.66% | -64.04% | 48/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 6.59% | -16.26% | 23.64% | 71/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.33% | -46.54% | 21.69% | 66/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.38% | -2.01% | 81.74% | 48/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.41% | 25.52% | -69.38% | 46/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 7.87% | -14.73% | -21.06% | 68/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 9.97% | 62.11% | 123.04% | 30/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.47% | -8.78% | 132.81% | 53/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.92% | -7.69% | -79.2% | 44/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 9.23% | -16.85% | 50.08% | 63/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6.15% | -19.71% | 25.51% | 46/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.9% | -8.58% | 135.58% | 39/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.08% | -20.31% | -81.26% | 38/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 11.1% | -29.88% | 44.91% | 47/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 7.66% | -28.68% | 42.91% | 34/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 5.36% | -21.41% | 105.36% | 34/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 2.61% | 2% | -83.51% | 33/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |